Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CSPC Pharmaceutical Group Ltd.
  6. Summary
    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LTD.

(1093)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-10-03 am EDT
7.800 HKD   +0.26%
09/29Hong Kong Hang Seng Down 0.5% as Property Issues Sustain Declines
MT
09/28Hong Kong Hang Seng Slumps 3.4%; Property and Tech Issues Sink
MT
09/20Chinese Regulator Approves CSPC Pharmaceutical's Drug Application
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
09/27/2022 09/28/2022 09/29/2022 09/30/2022 10/03/2022 Date
7.37(c) 7.4(c) 7.55(c) 7.78(c) 7.8 Last
30 436 518 30 191 813 45 107 473 54 155 234 25 192 583 Volume
+3.22% +0.41% +2.03% +3.05% +0.26% Change
More quotes
Estimated financial data (e)
Sales 2022 35 837 M 4 565 M 4 565 M
Net income 2022 6 958 M 886 M 886 M
Net cash position 2022 14 300 M 1 822 M 1 822 M
P/E ratio 2022 13,5x
Yield 2022 2,16%
Sales 2023 40 555 M 5 166 M 5 166 M
Net income 2023 7 926 M 1 010 M 1 010 M
Net cash position 2023 18 742 M 2 388 M 2 388 M
P/E ratio 2023 11,8x
Yield 2023 2,46%
Capitalization 92 703 M 11 809 M 11 809 M
EV / Sales 2022 2,19x
EV / Sales 2023 1,82x
Nbr of Employees 25 147
Free-Float 70,4%
More Financials
Company
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows: - drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%); - vitamin C (10.1%); - antibiotics (6.2%); - other (5%): including anhydrous and raw caffeine. Net sales are distributed geographically as follows: China... 
Sector
Pharmaceuticals
Calendar
11/17Earnings Release
More about the company
Ratings of CSPC Pharmaceutical Group Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about CSPC PHARMACEUTICAL GROUP LTD.
09/29Hong Kong Hang Seng Down 0.5% as Property Issues Sustain Declines
MT
09/28Hong Kong Hang Seng Slumps 3.4%; Property and Tech Issues Sink
MT
09/20Chinese Regulator Approves CSPC Pharmaceutical's Drug Application
MT
09/12Chinese Regulator Approves Clinical Trials for CSPC Pharmaceutical's Injection
MT
09/09CSPC Pharmaceutical Group Limited Announces TG103 Injection Obtains Clinical Trial Appr..
CI
09/08CSPC PHARMACEUTICAL GROUP LTD. : Ex-dividend day for inte..
FA
09/07Hong Kong Hang Seng Down 0.8% on Pandemic, China Trade Data
MT
08/26UBS Adjusts CSPC Pharmaceutical Group's Price Target to HK$11.80 From HK$13, Keeps at B..
MT
08/26CSPC PHARMACEUTICAL GROUP LTD. : Half-year report
CO
08/24CSPC Pharmaceutical Group Limited Declares Interim Dividend for the Six Months Ended 30..
CI
08/24CSPC Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June..
CI
08/23CSPC Pharmaceutical Group Limited Announces Completion of Clinical Study of Heterologou..
CI
08/19CSPC Pharmaceutical Group Limited Obtains Drug Registration Approval Granted by the Nat..
CI
08/19Chinese Regulator Approves Clinical Trial for CSPC Pharmaceutical's Liposome Injection
MT
08/18Cspc Pharmaceutical Group Limited Obtains Duoenda (Mitoxantrone Hydrochloride Liposome ..
CI
More news
News in other languages on CSPC PHARMACEUTICAL GROUP LTD.
09/29Le Hang Seng de Hong Kong en baisse de 0,5 % alors que les questions immobilières souti..
09/28Le Hang Seng de Hong Kong chute de 3,4 % ; l'immobilier et la technologie sont en baiss..
09/09CSPC Pharmaceutical Group Limited annonce que l'injection TG103 a obtenu l'approbation ..
09/07Le Hang Seng de Hong Kong en baisse de 0,8 % en raison de la pandémie et des données co..
08/24CSPC Pharmaceutical Group Limited déclare un dividende intérimaire pour les six mois se..
More news
Analyst Recommendations on CSPC PHARMACEUTICAL GROUP LTD.
More recommendations
ETFs positioned on CSPC PHARMACEUTICAL GROUP LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Global X MSCI China Health Care ETF - USD6.86%3.19%China
KraneShares MSCI All China Health Care Inde...3.4%5.54%China
Loncar China BioPharma ETF - Distributing - USD2.69%2.13%China
VanEck Global Healthcare Leaders ETF - AUD1.84%1.47%-NC
KraneShares MSCI China ESG Leaders ETF - USD1.26%-2.34%-China
More ETFs positioned on CSPC PHARMACEUTICAL GROUP LTD.
Chart CSPC PHARMACEUTICAL GROUP LTD.
Duration : Period :
CSPC Pharmaceutical Group Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSPC PHARMACEUTICAL GROUP LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 7,78 HKD
Average target price 12,03 HKD
Spread / Average Target 54,7%
EPS Revisions
Managers and Directors
Cui Long Zhang Vice Chairman & Chief Executive Officer
Dong Chen Cai Chairman
Bo Wang Independent Non-Executive Director
Chuan Chen Independent Non-Executive Director
Chun Kwok Au Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CSPC PHARMACEUTICAL GROUP LTD.-8.15%11 809
JOHNSON & JOHNSON-4.51%429 503
ELI LILLY AND COMPANY17.06%307 239
ROCHE HOLDING AG-14.68%271 055
PFIZER, INC.-25.89%245 597
ABBVIE INC.-0.88%237 296